	Esperanza NeuroPeptides ®
	\| HOME \| TREATMENT PROGRAM \| R & D \| Q & A \| TECHNOLOGIES \| TRAVEL TO OUR CLINICS \| NEWS \| PROFILE \| \| DOC TALK \| RECENT ARTICLES \| TESTIMONIALS \| EXECUTIVE SUMMARY \| TRAINING \| CONTACT US \| LEGAL \|

MSN EMAIL NEWSLETTER

ESPERANZA CLINICS

SUBSCRIBE TO MSN NEWS

POWERPOINT PRESENTATION

Click here for my testimonial

sclerosis (scle-ro-sis) - is the induration or hardening, especially from inflammation and in diseases of the interstitial substance; applied chiefly to such hardening of the nervous system primarily attributed to multiple sclerosis.

A4M CONVENTION - CHICAGO - AUGUST 2-4, 2007

Welcome to the Research Foundation website. Please feel free to explore the web site. We hope you will fill out the questionnaire below. Your information will not be shared with others. We value your input, and thank you in advance for helping us to better understand your concerns and the needs of your patients.

Required fields are marked with an asterisk (*)

*Title:
*First Name:
*Last Name:
Business Name:
*Address:

*City:
*State:
*Zip:
*Phone:
*Email:
How many patients do you see per year presenting with neurological symptoms?
How many patients presenting with Multiple Sclerosis (MS) do you see each year?
If your MS patients could regain speech, motor function and balance would you refer them?	yes no
Would you want to be trained (at no charge to you) to offer this sublingual peptide therapy?	yes no
Of the MS patients that you see, what are their three major complaints?
In your opinion, do the currently available MS drugs allow the patient to regain function?
In your opinion, do the currently available MS drugs offer significant improvement in quality of life?
We would appreciate you thoughts and comments?
We are considering providing training sessions at the Las Vegas meeting to certify practitioners. Would you prefer these sessions during the day or in the evening?	daytime evening
Would you be interested in attending?	yes no

On behalf of the clinical team, we thank you for your input, and look forward to seeing you again in Las Vegas.